A seminal meta-study has shed new light on the benefits of vitamin D supplementation for maintaining cardiometabolic health. Researchers from China and the United States analyzed 99 randomized controlled trials involving 17,656 participants worldwide, revealing significant advantages of taking vitamin D supplements.
The study found that a daily dose of 3,320 International Units (IU) of vitamin D, equivalent to 83 micrograms, was associated with notable reductions in systolic and diastolic blood pressure and verall cholesterol. It also links it with Hemoglobin A1C (a marker of type 2 diabetes) and fasting blood glucose and insulin.
To reconcile conflicting research findings, the researchers cataloged differences between the trials, enabling a more balanced comparison. This approach revealed that vitamin D supplementation provided the greatest benefits to Non-Western populations, individuals with lower circulating vitamin D levels, people with a BMI under 30 as well as those aged 50 and older.
The meta-study’s findings offer clarity on the role of vitamin D in maintaining cardiometabolic health, resolving inconsistencies in previous research. By identifying specific populations that benefit most from vitamin D supplementation, healthcare providers can make informed recommendations.
This comprehensive review underscores the importance of vitamin D in preventing and managing cardiometabolic diseases, such as heart disease, diabetes, and stroke. As researchers continue to explore the benefits of vitamin D, this study provides valuable insights for promoting public health and well-being.
toobit exchange